Details for New Drug Application (NDA): 011961
✉ Email this page to a colleague
NDA 011961 describes MARPLAN, which is a drug marketed by Lifsa Drugs and is included in one NDA. It is available from one supplier. Additional details are available on the MARPLAN profile page.
The generic ingredient in MARPLAN is isocarboxazid. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the isocarboxazid profile page.
The generic ingredient in MARPLAN is isocarboxazid. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the isocarboxazid profile page.
Summary for 011961
| Tradename: | MARPLAN |
| Applicant: | Lifsa Drugs |
| Ingredient: | isocarboxazid |
| Patents: | 0 |
Pharmacology for NDA: 011961
| Mechanism of Action | Monoamine Oxidase Inhibitors |
Medical Subject Heading (MeSH) Categories for 011961
Suppliers and Packaging for NDA: 011961
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MARPLAN | isocarboxazid | TABLET;ORAL | 011961 | NDA | Lifsa Drugs LLC | 72336-032 | 72336-032-01 | 100 TABLET in 1 BOTTLE, PLASTIC (72336-032-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
